V
Ventyx Biosciences (VTYX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Ventyx Biosciences (VTYX)
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet medical need. Its pipeline includes VT... Read more
- USD4.15
- USD4.15
- USD3.94
- USD40.58
- -36.70%
- --
- 586.71k
- 1.12M
- 315M
- 1.87
- -89.20%
Stock News
yesterday
Bristol Myers Squibb stock tumbles on cost-cutting initiative
Yahoo
yesterday
Alphabet stock pops off on Q1 earnings beat, cash dividend
Yahoo
yesterday
H&R Block to Release Fiscal 2024 Third Quarter Results on May 9, 2024
Yahoo
yesterday
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
